Genmab — November 2020

[transalp]

Go morgen..

[StockBull]

Breakout og profit target 2600 inden for kommende 11 dage https://nbg1.your-objectstorage.com/proinvestor-dev/forum/boards/88228_break_out.JPG

[Helge_LarsenPI-redaktør]

Genmab
@Genmab
·
1 t
Join us at 8:30 AM EST / 2:30 PM CET on Nov 13 for Capital Markets Day to hear more about our growing pipeline and capabilities. Register here: https://events.bizzabo.com/GenmabCMD

[Solsen]

Mon abstracts kommer på mandag ved middagstid. Eller er der nogen der ved hvornår på dagen ?

[E_L]

Embargo lifted and full regular and late-breaking abstracts made public at 8 a.m. EST

[E_L]

=+6 = 14 CET

[Solsen]

Tak så køber vi mandag i håb om at Genmab har fat i næste generations I/O drugs.

[E_L]

i am not sure if they will be able to show us much more than we have seen? Judith said the poster data might be updated for longer data, but that would only be 2-3 months from July?

[deleted-user]

Tror den lukker i 2500

[deleted-user]

Det var lige vel optimistisk. Nu skal weekenden nydes inden vi følger Genmab på vejen mod 2600 i næste uge -
som StockBull dikterer

[GeorgeBest]

On Nov. 16, President and CEO Jan G. J. van de Winkel is sitting down with @clivecookson of @FT in a fireside chat at @ConsiliumHC Annual Healthcare Virtual Conference. There is still time to register to catch this insightful conversation. onlinexperiences.com/scripts/Server… https://twitter.com/genmab/status/1324774759897407490?s=12

[GeorgeBest]

Genmab er deleme nået langt når selv Financial Times anmoder Jan om et Fireside Chat

[Peter_Panik]

Lidt vedr. HALO og medikamenterne Apollo, Andromeda, Daratumumab:

[Peter_Panik]

Access Denied

(www.marketscreener.com)

[Peter_Panik]

HALO er jo steget som en raket siden regnskabet for nogle dage siden.

[Helge_LarsenPI-redaktør]

God morgen.

[transalp]

Go morgen..

[E_L]

Saturday morning video - DuoBody-PD-L1x4-1BB (GEN1046) - in anticipation of an exciting week - https://www.youtube.com/watch?v=QmnXu-ZcoHM

[Bulder]

Thx E L. Makes Judith's bla bla from the other day more understandable. I think the "zipper" she is talking about is the immune synnapse between effector cell and target cell. 2:45 into the video.

[Helge_LarsenPI-redaktør]

Efter aflæggelse af Q3 regnskabet afholdte Genmabs ledelse med analytikerne, deres investorpræsentation som kan ses via dette link. Her har man mulighed for at høre Q&A med analytikerne efter ledelsens indledende præsentation. Genmab indleder præsentationen sådan: Company & Pipeline Highlights • U.S. FDA approval of Kesimpta (ofatumumab)1 in RMS • Epcoritamab2: 1st pt dosed in expansion cohort
…https://www.proinvestor.com/investornyt/669403/q3-webcast-se-genmabs-ledelse-i-qampa-med-analytikere